Press release
First-hand information, exhaustive and accurate, about our company
Capital increase strengthens ADL’s position
ADL BioPharma increases capital by EUR 24 million, which is 100% subscribed by Kartesia as the sole shareholder, by converting an equivalent amount of all its old loans in the company. In this way, ADL significantly reduces its debt ratios and financial interest...
The Minister of Industry of the Autonomous Government of Castilla y León visits ADL BioPharma
ADL BioPharma's facilities have received the visit of Mr. Mariano Veganzones Díez, Minister of Industry, Trade and Employment of the Junta de Castilla y León, and Mr. Fernando Campo González, General Director of Industry. With the help of our president and CEO, Mr....
The Intelligent Control group of the Spanish Committee of Automatics makes a technical visit to ADL BioPharma’s factory in the context of its XVII Symposium
ADL BioPharma has received this Tuesday 28th in its factory in León a representation of the attendees of the XVII Symposium of Intelligent Control of the Spanish Committee of Automatics, with the aim of strengthening ties and making a technical visit to the factory....
ADL BioPharma participates in “Expo León i4.0” fair
In ADL BioPharma we continue to strengthen ties with the University of Leon and betting on local talent. On May 20, we were present at the "Expo León i4.0" fair, which brought together about thirty companies from the technological and industrial sector of the province...
Boosting technology transfer through an agreement with the University of Leon
The Rector of the University of Leon, Juan Francisco García Marín, together with the Business Relations Department Director, Nuria González Rabanal, visited ADL BioPharma facilities on Thursday, May 12, and signed the agreement between both institutions. This...
ADL BioPharma closes 2021 with a turnover increase of more than 60%
ADL BioPharma had a turnover of nearly 38 million euros, thus increasing its sales by almost 14.5 million euros compared to 2020, and was able to sign long-term customer contracts. ADL BioPharma closed 2021 with a turnover of 38 million euros, which is almost 14.5...
ADL BioPharma and the Halal Institute sign a pioneering collaboration agreement in the biotechnology sector
The Halal Institute, with offices in Cordoba, Lisbon and Mexico City, will offer certification services for all the processes and products produced at ADL BioPharma facilities, while the Leon-based company will promote the application of the Islamic Board’s Halal...
ADL BioPharma renews its corporate image and consolidates itself as a strategic partner in Europe to accelerate and optimize biotechnology projects
In this new stage they are committed to innovation, resource optimization and the product quality from economic and environmental sustainability. The biopharmaceutical Company ADL BioPharma, with more than 60 years of experience in the biopharmaceutical sector, renews...
The Fire Brigade Sergeant of León visits ADL BioPharma premises
This visit shows the good coordination between the León Fire Brigade and ADL, and proves the factory's commitment to safety in all its facilities. On Friday 3rd December 2021, ADL BioPharma Emergency Directors and Intervention Managers received a visit from Santos...
ADL BioPharma receives the visit of the Mayor of León, in the final stretch of 2021. A year full of changes that provides a positive outcome
José Antonio Diez Díaz, Mayor of León, and Carmelo Alonso Sutil, Councillor for Economic Promotion, visited this morning ADL BioPharma facilities. On the course of this visit, they have been able to learn from Ignacio Urbelz Pérez, ADL BioPharma president and CEO,...
ADL BioPharma prioritises its workers safety by promoting a Preventive Culture Plan
This Plan focuses on information, training and self-responsibility and introduces safety measures such as the implementation of the Lockout and Tagout procedure (LOTO) or the simplification of Material Safety Data Sheets (MSDS), amongst others. At ADL BioPharma, our...
ADL BioPharma strengthens its financial position to undertake new investments
ADL BioPharma is carrying out a new capital increase of 12 million euros in order to reinforce its equity position and provide the financial strength to execute its Strategic Growth Plan. This increase has been signed 100% by its sole shareholder, Kartesia. In...
Capital Energy and ADL BioPharma sign a renewable energy provision contract and become strategic partners
Within the framework of both companies’ commitment to sustainable development Capital Energy will provide 61,000 megawatts hour (MWh) per year of clean and competitive power to this emblematic Leonese biotechnology company premises over the next five years....
ADL BioPharma renewed its “GMP food” certification
Last June, ADL BioPharma renewed its “GMP food” certification in compliance with the CODEX Alimentarius, for production through fermentation and recovery processes. In addition, it extends and certifies this quality system to its Fermentation Pilot Plant and the...
ADL’s pilot plant resumes its activity with two important projects
At the beginning of 2021 ADL resumed activity in the pilot plant in which the technology transfer of two projects is currently being carried out. One of them aims to produce a high-value product in the cosmetic industry, and the other focuses on the production of a...
ADL participates in CPhI Worldwide, the world’s most recognised pharmaceutical industry fair
In addition, they have also been present in the digital edition of the BIO International Convention, which brings together the main companies in the biotechnology sector. Between the 17th and 24th of May, ADL participated in the most important pharmaceutical industry...
